Learn to become a regulatory strategic business partner when developing and reviewing advertising, promotional and labeling materials, with a focus on discernment between on-label, extra-label, and off-label claims.
This workshop is intended for regulatory and compliance professionals that navigate FDA expectations for medical device communications. It will provide comprehensive coverage of the regulatory landscape governing medical device marketing and sales, including on-label, extra-label, and off-label communications under the Food, Drug, & Cosmetic Act and FDA guidance. Through real-world case studies (including the Acclarent criminal prosecution and recent Gilead/Novartis enforcement actions), interactive exercises, and practical decision-making frameworks, participants will learn to apply established principles for managing medical device communications. Key outcomes include the following: (1) distinguish between labeling, advertising, promotion, and distribution—and why that matters for claim review; (2) understand on-label, extra-label, and off-label communications, including when extra-label information can be communicated consistently with FDA-required labeling; (3) evaluate the latest FDA guidance on medical product communications, extra-label information, and scientific information on unapproved uses into promotional review and field coaching; and (4) navigate social media platforms, including character-space limitations, user-generated content, and misinformation—using recent FDA draft guidance and warning letters as benchmarks. Through this session, participants will collaborate on hypotheticals, review sample claims, and refine decision trees and risk evaluations for medical device communications.
Saint Cloud State University at Plymouth
9750 Rockford Rd
#100
Plymouth, MN 55442
RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation. All cancellation requests must be submitted in writing to [email protected]. Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.
Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email [email protected] with the event title, name of the original registrant and the contact information for the new attendee.
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email [email protected].


President, DuVal & Associates, P.A.
Bryan Feldhaus, JD, LL.M., is President of DuVal & Associates, P.A. Bryan specializes in advising medical device, pharmaceutical and nutritional supplement companies on FDA law, regulations and guidance. His practice includes providing legal/regulatory advice in designing and implementing sophisticated marketing programs (considering FDA’s advertising and promotional regulations, the Anti-kickback Statute, False Claims Act and the Physician Payments Sunshine Act), conducting sales training, and interfacing extensively on behalf of companies with the FDA on promotional, inspectional and other enforcement matters. He also provides strategic advice and advocacy regarding clinical trials and regulatory submissions. Additionally, Bryan counsels companies on compliance matters, conducts compliance assessments, collaborates with clients to develop compliance programs, and provides compliance training to ensure clients understand and achieve their compliance goals in the context of their business objectives. Finally, Bryan advises medtech companies regarding their HIPAA and GDPR obligations as it relates to their relationship to patient data.
Prior to joining DuVal & Associates, Bryan enjoyed a fourteen-year career as a trial and litigation shareholder at a Minneapolis law firm. As a former litigation attorney, Bryan is experienced in trial and appellate matters, is admitted to practice in state and federal courts, and is experienced in commercial litigation and intellectual property matters, including patent and trademark litigation.
Bryan is a 2006 graduate from the University of St. Thomas School of Law. He obtained an LL.M. degree in Corporate Compliance and Organizational Ethics from the University of St. Thomas School of Law. He also obtained a Cybersecurity and Privacy Law Certificate from Mitchell Hamline School of Law in 2019.
We have completed our migration to a new platform and are pleased to introduce the updated site.
What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.
We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.
We welcome your feedback. Please let us know how we can continue to improve your experience.